Mucinex Tablet, Extended Release
NDC Package 55154-4680-0

11-digit billing NDC: 55154468000

Package Information

Mucinex (guaifenesin) tablets is •do not crush, chew, or break tablet •take with a full glass of water •this product can be administered without regard for the timing of meals •adults and children 12 years of age and over: 1 or 2 tablets every 12 hours. This formulation utilizes a tablet, extended release delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-4680 and is authorized under FDA application NDA021282.

Identification & Billing

NDC Package Code
55154-4680-0
Package Description
10 BLISTER PACK in 1 BAG / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
55154468000
RxNorm Crosswalk
  • RxCUI: 636522 - guaiFENesin 600 MG 12HR Extended Release Oral Tablet
  • RxCUI: 636522 - 12 HR guaifenesin 600 MG Extended Release Oral Tablet
  • RxCUI: 636522 - guaifenesin 600 MG 12 HR Extended Release Oral Tablet
  • RxCUI: 891301 - Mucinex Expectorant 600 MG 12HR Extended Release Oral Tablet
  • RxCUI: 891301 - 12 HR guaifenesin 600 MG Extended Release Oral Tablet [Mucinex]

Clinical Specifications

Proprietary Name
Mucinex
Non-Proprietary Name
Guaifenesin
Substance Name
Guaifenesin
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
•do not crush, chew, or break tablet •take with a full glass of water •this product can be administered without regard for the timing of meals •adults and children 12 years of age and over: 1 or 2 tablets every 12 hours. Do not exceed 4 tablets in 24 hours. •children under 12 years of age: do not use

Regulatory & Marketing

Labeler Name
Cardinal Health 107, Llc
Product Type
Human Otc Drug
FDA Application #
NDA021282
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-01-2016
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-4680-0 identifies a specific commercial package of 10 blister pack in 1 bag / 1 tablet, extended release in 1 blister pack of Mucinex, a human over the counter drug labeled by Cardinal Health 107, Llc. This tablet, extended release is formulated for oral use and contains guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on January 01, 2016. The current certification is valid through December 31, 2027.

How is this Cardinal Health 107, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154468000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-4680-0
11-Digit CMS (5-4-2)
55154-4680-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.